FDA Submits Collection of Information for Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, related to the use of public human genetic variant databases to support clinical validity for genetic and genomic-based in vitro diagnostics.